fda cleared semaglutide immunoassay (Ozempic™) ELISA FDA free to pursue semaglutide

6,9,12 Prevention is key People with diabetes, especially older adults, are more likely to experience severe symptoms and long-term complications if they contract shingles

Earlier data from PIONEER 6 and SUSTAIN 6 suggested a CV benefit of semaglutide at lower doses in individuals with type 2 diabetes

Many patients feel jittery without realizing their coffee is the problem

DPP-IV activity is upregulated during inflammatory responses, and preclinical models of colitis have demonstrated that DPP-IV inhibitors reduced the expression of proinflammatory cytokines and improved histological outcomes ( Emerging hypothesis and therapeutic rationale Translational studies have sought to map the protective properties of GLP-1 and GLP-2 to clinical applications for patients with IBD

Whether those effects translate directly to women in the GLP-1-therapy-plus-weight-loss context requires additional research that hasn't been published yet